How understanding barriers to early treatment can transform healthcare
Recent scientific advances have made it possible to detect, diagnose and treat devastating diseases, including Alzheimer’s disease, earlier than ever before. But now, people need to be convinced to get care. New Ipsos research indicates that patient refusal of care is a major barrier to better long-term health.
By prescribing therapies earlier, clinicians can make a life-changing difference for their patients. But first, patients must trust and understand that a diagnosis is not a sentence, but an opportunity.
Yet real clinical environments are complex, and patient decision-making is complicated. The best practices shared by healthcare practitioners and the broader medical community can help. Now, it’s possible to monitor and learn from these experiences through a multi-client Alzheimer’s Monitor that Ipsos has launched in the U.S.
These collective insights cast light on opportunities to build trust and improve patient education. And if that knowledge is used to shift perspectives on diagnoses from fear to empowerment, it can make a difference — as Alzheimer’s cases are projected to double to 13 million Americans by 2050. Early intervention could cut this trajectory, extending independence and quality of life for millions.
← Read previous | Read next → |